Jilin hospital marks progress in Da Vinci surgical robot application
A surgical operation deploying the fourth-generation Da Vinci robot [Photo provided to chinadaily.com.cn]
The China-Japan Union Hospital of Jilin University in Changchun, Northeast China's Jilin province, has marked progress in the application of the fourth-generation Da Vinci surgical robot, with 1,000 surgical operations being completed with the surgical robot from March 3, 2020 to April 23, 2021.
The hospital ranks first in the country in terms of the number of surgical operations deploying the fourth-generation Da Vinci robot after being introduced in March 2020.
The hospital boasts the first Da Vinci surgical robot digital operating room in Jilin province.
The fourth-generation Da Vinci surgical robot is currently recognized as the most advanced surgical robot in the world. Compared with traditional thoracoscopy, it has a clearer and more realistic 3D surgical field of vision, and has intelligent image processing functions that automatically switch from multiple angles.
The equipped robotic operating arm is stabler and more accurate, greatly improving the flexibility and control range of surgical operations in narrow cavities.
The Da Vinci surgical robot medical team carries out a surgery. [Photo provided to chinadaily.com.cn]
The fourth-generation Da Vinci surgical robot was launched in the United States in 2014 and was approved for the Chinese product registration certificate in December 2018.
At the beginning of 2019, Jilin hospital submitted its procurement plan. In April of the same year, the Da Vinci surgical robot medical team was established.
Training sessions on the application and operation of the fourth-generation Da Vinci surgical robot have been developed.
In the future, the fourth-generation Da Vinci surgical robot will be used in multiple departments at the Jilin hospital, including hepatobiliary and pancreatic surgery, thyroid surgery, urology, and thoracic surgery, as well as for surgical operations including cholecystectomy, prostate tumor resection, lobectomy, and complex hysteroscopic myomectomy.